Hims & Hers Health (HIMS) director awarded 957 RSUs for Q1 fees

Rhea-AI Filing Summary

WELLS DAVID B reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. director David B. Wells received a grant of 957 restricted stock units as part of his 2026 first-quarter board compensation. The RSUs were issued in lieu of $22,000 of cash retainer and committee fees, using a grant price of $22.98 per unit. Each RSU represents a contingent right to receive one share of Class A common stock and will vest in full on the company’s next quarterly vesting date. Following this compensation grant, Wells holds 957 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WELLS DAVID B

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	957	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 957 shares (Direct, null)

Footnotes (1)

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

RSUs granted: 957 units Foregone cash fees: $22,000 Grant price: $22.98 +1 more

4 metrics

RSUs granted 957 units Director compensation grant for first quarter of 2026

Foregone cash fees $22,000 Director retainer and committee membership fees converted to RSUs

Grant price $22.98 Used to calculate number of RSUs from $22,000 fees

RSUs after transaction 957 units Total RSUs held directly by David B. Wells following grant

Key Terms

Restricted Stock Unit, Director Compensation Policy, grant price, Class A Common Stock

4 terms

Restricted Stock Unit financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy"

grant price financial

"calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98"

Class A Common Stock financial

"contingent right to receive one share of Class A Common Stock for each RSU"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELLS DAVID B

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	05/20/2026		A		957		06/15/2026	(2)	Class A Common Stock	957	$0	957	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $22,000 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for David B Wells	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Hims & Hers (HIMS) director David B. Wells receive in this Form 4?

Director David B. Wells received 957 restricted stock units as compensation. These RSUs were granted as part of his 2026 first-quarter board retainer and committee fees, replacing cash payments with equity tied to Hims & Hers Health, Inc.’s Class A common stock.

How was the HIMS director’s RSU grant amount of 957 units calculated?

The 957 RSUs were calculated by dividing foregone cash fees of $22,000 by a grant price of $22.98. This converts the director’s quarterly retainer and committee fees into equity-based compensation rather than a cash payout for the first quarter of 2026.

What does each Hims & Hers RSU granted to David B. Wells represent?

Each RSU represents a contingent right to receive one share of Hims & Hers Class A common stock. When the RSUs vest, the director is entitled to receive one share per unit, aligning his compensation more directly with the company’s share performance over time.

When will David B. Wells’ 957 HIMS RSUs vest?

The 957 RSUs will vest in full on the company’s next quarterly vesting date. Until that vesting date, they remain contingent rights, after which the RSUs convert into shares of Class A common stock if the standard vesting conditions are satisfied.

Is this Hims & Hers Form 4 a market purchase or a compensation grant?

This Form 4 reflects a compensation grant, not a market purchase. The RSUs were issued under the issuer’s Director Compensation Policy in lieu of $22,000 of cash fees, with a grant price of $22.98, and are structured as equity awards that vest on a set schedule.

How many Hims & Hers RSUs does David B. Wells hold after this transaction?

After this grant, David B. Wells holds 957 RSUs directly according to the filing. These RSUs correspond to potential future shares of Class A common stock, contingent on vesting at the company’s next quarterly vesting date under the compensation arrangement.